L-base
Developer of an autophagy-targeted drug intended to overcome resistance to existing anticancer drugs. The company intends to develop therapeutic agents that can overcome resistance to targeted antican...
Valuation
$0
Share Price
N/A
Total Raised
$3.3B
Last Round
N/A